Case Reports
Vol. 3 No. 3 (2018)
https://doi.org/10.4081/ozone.2018.7970

Effects of oxygen-ozone therapy in the Roth syndrome: a case report

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 4 December 2018
Published: 18 December 2018
938
Views
528
Downloads
410
HTML
Roth syndrome, Meralgia paresthetica, Lateral femoral cutaneous nerve, Oxygen-ozone therapy

Authors

Alfredo Romeo
alfredo.romeo@tin.it
Department of Physical and Rehabilitation Medicine, “Umberto I” Hospital, Siracusa; Italian Society for Oxygen-Ozone Therapy (SIOOT), Gorle (BG), Italy.
Carolina Baiano
Physical and Rehabilitation Medicine Health District, Provincial Health Authority, Siracusa, Italy.
Marianna Chierchia
“Luigi Vanvitelli” University of Campania, Italy.
Francesco Scandone
“A. Landolfi” Pain Control Center, Solofra (AV), Italy.

Meralgia paresthetica (MP) is a disesthetic and/or anesthetic syndrome in the distribution of the lateral femoral cutaneous nerve. It is a compressive or traumatic mononeuropathy, characterized by burning pain and/or discomfort in the anterolateral thigh, without motor or muscle strength changes, with preserved reflexes. The authors report the case of a 52-year-old male with a history of low back pain presented from two-year sensory dysesthesias and paresthesias in the right anterolateral thigh, consistent with meralgia paresthetica; they also describe the first reported use of O2O3 therapy to relieve the intractable pain associated with MP.

Downloads

Download data is not yet available.

How to Cite



Effects of oxygen-ozone therapy in the Roth syndrome: a case report. (2018). Ozone Therapy, 3(3). https://doi.org/10.4081/ozone.2018.7970

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.